Cargando…
Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms
INTRODUCTION: Long COVID is the overarching name for a wide variety of disorders that may follow the diagnosis of acute SARS-COVID-19 infection and persist for weeks to many months. Nearly every organ system may be affected. METHODS: We report nine patients suffering with Long COVID for 101 to 547 d...
Autores principales: | Thompson, John S., Thornton, Alice C., Ainger, Timothy, Garvy, Beth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932260/ https://www.ncbi.nlm.nih.gov/pubmed/36818469 http://dx.doi.org/10.3389/fimmu.2022.1033651 |
Ejemplares similares
-
Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
por: Kerr, Jacqueline, et al.
Publicado: (2014) -
Case Report: High-dose immunoglobulins prior to plasma exchange in severe pulmonary renal syndrome
por: Schäfer, Ann-Kathrin, et al.
Publicado: (2023) -
Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders
por: Zografou, C., et al.
Publicado: (2021) -
High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019) -
Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine
por: Diez-Feijóo, Ramon, et al.
Publicado: (2022)